Nothing Special   »   [go: up one dir, main page]

Vaish et al., 2021 - Google Patents

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity and therapeutic targeting

Vaish et al., 2021

View HTML
Document ID
6442316567346446624
Author
Vaish U
Jain T
Are A
Dudeja V
Publication year
Publication venue
International journal of molecular sciences

External Links

Snippet

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related morbidity and mortality in the western world, with limited therapeutic strategies and dismal long-term survival. Cancer-associated fibroblasts (CAFs) are key components of the pancreatic tumor …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
Vaish et al. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity and therapeutic targeting
Arneth Tumor microenvironment
Medeiros et al. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives
Barbato et al. Cancer stem cells and targeting strategies
Truong et al. Pancreatic cancer microenvironment and cellular composition: current understandings and therapeutic approaches
Freeman et al. Cancer-associated fibroblast mediated inhibition of CD8+ cytotoxic T cell accumulation in tumours: mechanisms and therapeutic opportunities
Del Prete et al. Functional role of dendritic cell subsets in cancer progression and clinical implications
Galassi et al. The immune privilege of cancer stem cells: a key to understanding tumor immune escape and therapy failure
Harryvan et al. Targeting of the cancer-associated fibroblast—t-cell axis in solid malignancies
Zhang et al. Mechanisms of immunosuppression in colorectal cancer
Orsini et al. Defective generation and maturation of dendritic cells from monocytes in colorectal cancer patients during the course of disease
Ben Khelil et al. Harnessing antitumor CD4+ T cells for cancer immunotherapy
Morimoto et al. CRISPR-Cas9–mediated TIM3 knockout in human natural killer cells enhances growth inhibitory effects on human Glioma cells
Cheever et al. Tumor microenvironment immunosuppression: a roadblock to CAR T-cell advancement in solid tumors
Nava et al. Dendritic cells and cancer immunotherapy: The adjuvant effect
Papait et al. Fight the cancer, hit the CAF!
Lucarini et al. Dendritic cells: behind the scenes of T-cell infiltration into the tumor microenvironment
Henze et al. Enhancing the efficacy of CAR T cells in the tumor microenvironment of pancreatic cancer
Shaik Fakiruddin et al. Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour
Park et al. Preferential expression of programmed death ligand 1 protein in tumor-associated macrophages and its potential role in immunotherapy for hepatocellular carcinoma
Singh et al. Gap junctions in the bone marrow lympho-hematopoietic stem cell niche, leukemia progression, and chemoresistance
Zhang et al. Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma
Hilmi et al. Cancer-associated fibroblasts: accomplices in the tumor immune evasion
Huang et al. The role of indoleamine 2, 3-dioxygenase 1 in regulating tumor microenvironment
Abdelmoneim et al. The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies